Next Article in Journal
Leczenie Zaawansowanego Niedrobnokomórkowego Raka Płuca—W Którym Miejscu Jesteśmy?
Previous Article in Journal
Guzkowy Rozrost Limfoidalny—Rzadki Przypadek Choroby Limfoproliferacyjnej w Płucach
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Genetyczne Warianty alfa-1 Antytrypsyny—Klasyfikacja i Znaczenie Kliniczne

by
Beata Popławska
1,
Sabina Janciauskiene
2 and
Joanna Chorostowska-Wynimko
1,*
1
Samodzielna Pracownia Diagnostyki Molekularnej i Immunologii, Instytut Gruźlicy i Chorób Płuc w Warszawie, ul. Płocka 26, 01-138 Warszawa, Poland
2
Klinika Chorób Płuc, Uniwersytet Medyczny w Hanowerze, Niemcy, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2013, 81(1), 45-54; https://doi.org/10.5603/ARM.27530
Submission received: 25 April 2012 / Revised: 13 December 2012 / Accepted: 13 December 2012 / Published: 13 December 2012

Abstract

Inherited alpha-1 antitrypsin deficiency is listed among the three most common genetic disorders in Caucasians. It considerably increases the risk of progressive obstructive lung diseases, mostly chronic obstructive pulmonary disease, as well as chronic liver disorders, hepatitis, cirrhosis, and cancer. It is estimated that more than 5.5% of the Polish population carries one of the most common deficiency phenotypes, which might be relatively easily detected due to low alpha-1 antitrypsin serum concentration. However, as well as being quantitative, alpha-1 antitrypsin deficiency might also be qualitative. These dysfunctional alpha-1 antitrypsin variants are characterized by scarce antiproteolytic activity and quite often by fully effective protein production resulting in normal serum levels. Consequently, dysfunctional variant identification is possible only by means of pheno- or genotyping. This review presents clinically useful characteristics of main genetic alpha-1 antitrypsin variants.
Keywords: alpha-1 antitrypsin deficiency; genetic variants of alpha-1 antitrypsin; chronic obstructive pulmonary disease alpha-1 antitrypsin deficiency; genetic variants of alpha-1 antitrypsin; chronic obstructive pulmonary disease

Share and Cite

MDPI and ACS Style

Popławska, B.; Janciauskiene, S.; Chorostowska-Wynimko, J. Genetyczne Warianty alfa-1 Antytrypsyny—Klasyfikacja i Znaczenie Kliniczne. Adv. Respir. Med. 2013, 81, 45-54. https://doi.org/10.5603/ARM.27530

AMA Style

Popławska B, Janciauskiene S, Chorostowska-Wynimko J. Genetyczne Warianty alfa-1 Antytrypsyny—Klasyfikacja i Znaczenie Kliniczne. Advances in Respiratory Medicine. 2013; 81(1):45-54. https://doi.org/10.5603/ARM.27530

Chicago/Turabian Style

Popławska, Beata, Sabina Janciauskiene, and Joanna Chorostowska-Wynimko. 2013. "Genetyczne Warianty alfa-1 Antytrypsyny—Klasyfikacja i Znaczenie Kliniczne" Advances in Respiratory Medicine 81, no. 1: 45-54. https://doi.org/10.5603/ARM.27530

Article Metrics

Back to TopTop